Novel strategies for improving physical function

Hormone Research in Paediatrics

Volumn 76, Issue SUPPL. 1, 2011, Pages 17-23

  Bhasin, Shalender ^a   Jasuja, Ravi ^a   Tu, Powen ^a   Storer, Thomas W ^a   Guo, Wen ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Androgens; Improved physical function; Myostatin inhibitors

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; BETA CATENIN; BICALUTAMIDE; CYTOKINE RECEPTOR ANTAGONIST; DOXORUBICIN; FOLLISTATIN; FOLLISTATIN RELATED PROTEIN; GROWTH HORMONE SECRETAGOGUE; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN; METALLOPROTEINASE; MYOD PROTEIN; MYOGENIN; MYOSTATIN; MYOSTATIN ANTAGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROCOLLAGEN C PROTEINASE; PROTEIN KINASE B; PROTEIN PRECURSOR; SELECTIVE ANDROGEN RECEPTOR MODULATOR; SMAD PROTEIN; SOMATOMEDIN C; TESTOSTERONE; TRANSCRIPTION FACTOR FOXO; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

AFRICA; AGING; ANDROGEN THERAPY; ATHLETIC PERFORMANCE; BEHAVIOR; CELL DIFFERENTIATION; CONFERENCE PAPER; DISABILITY; DOWN REGULATION; EXERCISE; FALLING; FATTY LIVER; FRACTURE; GENE EXPRESSION; HEALTH CARE UTILIZATION; HISTOCOMPATIBILITY; HOMEOSTASIS; HOSPITALIZATION; HYPERTROPHY; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID STORAGE; META ANALYSIS (TOPIC); MORTALITY; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE GROWTH; MUSCLE HYPERTROPHY; MUSCLE MASS; MUSCLE STRENGTH; NONHUMAN; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PUBERTY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANCE TRAINING; SATELLITE CELL; SKELETAL MUSCLE; STEM CELL; TRANSGENE; UNITED STATES; UPREGULATION; WALKING DIFFICULTY;

AGED; AGED, 80 AND OVER; AGING; ANABOLIC AGENTS; ANDROGENS; ANIMALS; BODY COMPOSITION; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MALE; MUSCLE, SKELETAL; MYOSTATIN; TESTOSTERONE;

EID: 79960704265     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000329148     Document Type: Conference Paper

References (61)

1. Bureau UC 2004 American Community Survey. Available at: http://factfinder.census.gov/servlet/STTable-bm=y&-qr-name=ACS-2004-EST.
2. Freedman V, Martin L, Schoeni R: Recent trends in disability and functioning among older adults in the United States: a systematic review. JAMA 2002; 288: 3137-3146. (Pubitemid 36014131)
3. U.S. Department of Commerce, U.S. Census Bureau: Americans with disabilities: household economic studies; in: Census. Bot ed. Washington, 2001.
4. U.S. General Accounting Office: Report to Congressional Requesters. SSA disability. Other programs may provide lessons for improving return-to-work efforts. In: GAO-01-ed. Washington, 2000.
5. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM: Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2006; 91: 1995-2010. (Pubitemid 43854972)
6. Bhasin S, Woodhouse L, Storer TW: Proof of the effect of testosterone on skeletal muscle. J Endocrinol 2001; 170: 27-38. (Pubitemid 32677563)
7. Wilson J: Androgen abuse by athletes. Endocr Rev 1988; 9: 181-191.
8. Roy TA, Blackman MR, Harman SM, Tobin JD, Schrager M, Metter EJ: Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am J Physiol Endocrinol Metab 2002; 283:E284-E294. (Pubitemid 34827443)
9. van den Beld AW, de Jong FH, Grobbee DE, Pols HA, Lamberts SW: Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 2000; 85: 3276-3282.
10. Iannuzzi-Sucich M, Prestwood KM, Kenny AM: Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci 2002; 57:M772-M777. (Pubitemid 35470952)
11. Szulc P, Duboeuf F, Marchand F, Delmas PD: Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study. Am J Clin Nutr 2004; 80: 496-503.
12. Melton LJ 3rd, Khosla S, Crowson CS, O'Connor MK, O'Fallon WM, Riggs BL: Epidemiology of sarcopenia. J Am Geriatr Soc 2000; 48: 625-630. (Pubitemid 30390451)
13. Melton LJ 3rd, Khosla S, Riggs BL: Epidemiology of sarcopenia. Mayo Clin Proc 2000; 75(suppl):S10-S12, discussion S12-S13.
14. Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ: Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 1999; 107: 123-136. (Pubitemid 29138849)
15. Baumgartner RN, Waters DL, Morley JE, Patrick P, Montoya GD, Garry PJ: Age-related changes in sex hormones affect the sex difference in serum leptin independently of changes in body fat. Metabolism 1999; 48: 378-384. (Pubitemid 29116003)
16. O'Donnell AB, Travison TG, Harris SS, Tenover JL, McKinlay JB: Testosterone, dehydroepiandrosterone and physical performance in older men: results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2006; 91: 425-431. (Pubitemid 43236905)
17. Schaap LA, Pluijm SM, Smit JH, van Schoor NM, Visser M, Gooren LJ, Lips P: The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women. Clin Endocrinol (Oxf) 2005; 63: 152-160. (Pubitemid 41097983)
18. Orwoll E, Lambert LC, Marshall LM, Blank J, Barrett-Connor E, Cauley J, Ensrud K, Cummings SR: Endogenous testosterone levels, physical performance, and fall risk in older men. Arch Intern Med 2006; 166: 2124-2131. (Pubitemid 44631401)
19. Meier C, Nguyen TV, Handelsman DJ, Schindler C, Kushnir MM, Rockwood AL, Meikle AW, Center JR, Eisman JA, Seibel MJ: Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med 2008; 168: 47-54.
20. Szulc P, Claustrat B, Marchand F, Delmas PD. Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study. J Clin Endocrinol Metab 2003; 88: 5240-5247. (Pubitemid 37452722)
21. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A: Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996; 81: 4358-4365. (Pubitemid 26412044)
22. Katznelson L, Rosenthal DI, Rosol MS, Anderson EJ, Hayden DL, Schoenfeld DA, Klibanski A: Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism. AJR Am J Roentgenol 1998; 170: 423-427. (Pubitemid 28083851)
23. Bhasin S, Calof OM, Storer TW, Lee ML, Mazer NA, Jasuja R, Montori VM, Gao W, Dalton JT: Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab 2006; 2: 146-159.
24. Bhasin S, Storer TW, Berman N, Yarasheski KE, Clevenger B, Phillips J, Lee WP, Bunnell TJ, Casaburi R: Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 1997; 82: 407-413. (Pubitemid 27068601)
25. Brodsky IG, Balagopal P, Nair KS: Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men-a clinical research center study. J Clin Endocrinol Metab 1996; 81: 3469-3475. (Pubitemid 26339901)
26. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N: Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone Gel Study Group. J Clin Endocrinol Metab 2000; 85: 2839-2853. (Pubitemid 32269162)
27. Steidle C, Schwartz S, Jacoby K, Sebree T, Smith T, Bachand R: AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab 2003; 88: 2673-2681. (Pubitemid 36724441)
28. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, Casaburi R: The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996; 335: 1-7. (Pubitemid 26230806)
29. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad JG Jr, Strom BL: Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999; 84: 1966-1972. (Pubitemid 30647018)
30. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, Strom BL: Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999; 84: 2647-2653. (Pubitemid 30641987)
31. Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL: Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005; 90: 1502-1510. (Pubitemid 40464011)
32. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG: Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 2001; 56:M266-M272. (Pubitemid 32381803)
33. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton LJ 3rd, Smith GE, Khosla S, Jensen MD: DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006; 355: 1647-1659. (Pubitemid 44583955)
34. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, Bosch JL, Grobbee DE, van der Schouw YT: Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 2008; 299: 39-52.
35. Bhasin S, Buckwalter JG: Testosterone supplementation in older men: a rational idea whose time has not yet come. J Androl 2001; 22: 718-731. (Pubitemid 32781257)
36. Ferrando AA, Sheffield-Moore M, Yeckel CW, Gilkison C, Jiang J, Achacosa A, Lieberman SA, Tipton K, Wolfe RR, Urban RJ: Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 2002; 282:E601-E607. (Pubitemid 34654776)
37. Bhasin S, Espeland MA, Evans WJ, Ferrucci L, Fried LP, Gill TM, Pahor M, Studenski S, Guralnik J, Nayfield S, Romashkin S, Perlstein R, Burke L, Parks M: Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. J Gerontol A Biol Sci Med Sci 2009; 64: 487-491.
38. Storer TW, Woodhouse L, Magliano L, Singh AB, Dzekov C, Dzekov J, Bhasin S: Changes in muscle mass, muscle strength and power, but not physical function are related to testosterone dose in healthy older men. J Am Geriatr Soc 2008; 56: 1991-1999.
39. Sinha-Hikim I, Artaza J, Woodhouse L, Gonzalez-Cadavid N, Singh AB, Lee MI, Storer TW, Casaburi R, Shen R, Bhasin S: Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab 2002; 283:E154-E164. (Pubitemid 34686681)
40. Sinha-Hikim I, Cornford M, Gaytan H, Lee ML, Bhasin S: Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab 2006; 91: 3024-3033. (Pubitemid 44271751)
41. Sinha-Hikim I, Roth SM, Lee MI, Bhasin S: Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab 2003; 285:E197-E205. (Pubitemid 36736377)
42. Bhasin S, Taylor WE, Singh R, Artaza J, Sinha-Hikim I, Jasuja R, Choi H, Gonzalez-Cadavid NF: The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action. J Gerontol A Biol Sci Med Sci 2003; 58:M1103-M1110.
43. Singh R, Artaza JN, Taylor WE, Braga M, Yuan X, Gonzalez-Cadavid NF, Bhasin S: Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with betacatenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 2006; 147: 141-154. (Pubitemid 43004269)
44. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S: Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 2003; 144: 5081-5088. (Pubitemid 37378423)
45. Singh R, Bhasin S, Braga M, Artaza JN, Pervin S, Taylor WE, Krishnan V, Sinha SK, Rajavashisth TB, Jasuja R: Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/betacatenin and follistatin/transforming growth factor-beta signaling pathways. Endocrinology 2009; 150: 1259-1268.
46. Gupta V, Bhasin S, Guo W, Singh R, Miki R, Chauhan P, Choong K, Tchkonia T, Lebrasseur NK, Flanagan JN, Hamilton JA, Viereck JC, Narula NS, Kirkland JL, Jasuja R: Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes. Mol Cell Endocrinol 2008: 296: 32-40.
47. McPherron AC, Lawler AM, Lee SJ: Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83-90. (Pubitemid 27202654)
48. Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, Wolfman NM, Qiu Y: The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 2002; 277: 40735-40741. (Pubitemid 35215657)
49. Lee SJ: Genetic analysis of the role of proteolysis in the activation of latent myostatin. PLoS ONE 2008; 3:e1628.
50. Hill JJ, Qiu Y, Hewick RM, Wolfman NM: Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. Mol Endocrinol 2003; 17: 1144-1154. (Pubitemid 36683721)
51. Wolfman NM, McPherron AC, Pappano WN, Davies MV, Song K, Tomkinson KN, Wright JF, Zhao L, Sebald SM, Greenspan DS, Lee SJ: Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci USA 2003; 100: 15842-15846. (Pubitemid 38021077)
52. Anderson SB, Goldberg AL, Whitman M: Identification of a novel pool of extracellular pro-myostatin in skeletal muscle. J Biol Chem 2008; 283: 7027-7035.
53. Haidet AM, Rizo L, Handy C, Umapathi P, Eagle A, Shilling C, Boue D, Martin PT, Sahenk Z, Mendell JR, Kaspar BK: Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci USA 2008; 105: 4318-4322. (Pubitemid 351754378)
54. Qiao C, Li J, Jiang J, Zhu X, Wang B, Li J, Xiao X: Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice. Hum Gene Ther 2008; 19: 241-254.
55. Liu CM, Yang Z, Liu CW, Wang R, Tien P, Dale R, Sun LQ: Myostatin antisense RNAmediated muscle growth in normal and cancer cachexia mice. Gene Ther 2008; 15: 155-160. (Pubitemid 351150039)
56. Lee SJ: Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. PLoS ONE 2007; 2:e789.
57. Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, Hill JJ, Jalenak M, Kelley P, Knight A, Maylor R, O'Hara D, Pearson A, Quazi A, Ryerson S, Tan XY, Tomkinson KN, Veldman GM, Widom A, Wright JF, Wudyka S, Zhao L, Wolfman NM: Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 2003; 300: 965-971. (Pubitemid 36262030)
58. Lee SJ: Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 2004; 20: 61-86.
59. Guo W, Flanagan J, Jasuja R, Kirkland J, Jiang L, Bhasin S: The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways. J Biol Chem 2008; 283: 9136-9145.
60. Izumiya Y, Hopkins T, Morris C, Sato K, Zeng L, Viereck J, Hamilton JA, Ouchi N, LeBrasseur NK, Walsh K: Fast/glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab 2008; 7: 159-172. (Pubitemid 351168553)
61. Working Group on Functional Outcome Measures for Clinical Trials: Functional outcomes for clinical trials in frail older persons: time to be moving. J Gerontol A Biol Sci Med Sci 2008; 63: 160-164.